Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Ryohei, Abe"'
Autor:
Chie Asou, Tomoyuki Sakamoto, Kodai Suzuki, Itoko Okuda, Atsushi Osaki, Ryohei Abe, Yoshihiro Ito, Emi Kakegawa, Yoshitaka Miyakawa, Yasuhito Terui, Yuichi Nakamura
Publikováno v:
Journal of Medical Case Reports, Vol 18, Iss 1, Pp 1-5 (2024)
Abstract Background Blast transformation is a rare but well-recognized event in Philadelphia-negative myeloproliferative neoplasms associated with a poor prognosis. Secondary acute myeloid leukemias evolving from myeloproliferative neoplasms are char
Externí odkaz:
https://doaj.org/article/20ad831a1d844d00a58a9546ec999cd6
Autor:
Miki Sakamoto, Kohei Shiroshita, Shinya Fujita, Himari Kudo, Ryohei Abe, Sumiko Kohashi, Yuka Shiozawa, Kuniaki Nakanishi, Takaaki Toyama
Publikováno v:
eJHaem, Vol 5, Iss 3, Pp 638-641 (2024)
Externí odkaz:
https://doaj.org/article/31cfd2fe2edc498388b71be1181768fd
Autor:
Risa Shindo, Ryohei Abe, Kenji Oku, Tomoki Tanaka, Yu Matsueda, Tatsuhiko Wada, Yoshiyuki Arinuma, Sumiaki Tanaka, Tatsuyoshi Ikenoue, Yoshitaka Miyakawa, Kunihiro Yamaoka
Publikováno v:
Immunological Medicine, Vol 46, Iss 4, Pp 182-190 (2023)
AbstractImmune thrombocytopenia (ITP) is a thrombocytopenic condition induced by autoimmune mechanisms and includes secondary ITP with underlying diseases such as connective tissue diseases (CTD). In recent years, it has been elucidated that the subs
Externí odkaz:
https://doaj.org/article/3e5ef2fc9020436f907727193ec8db7a
Autor:
Shinya Fujita, Hidenori Kasahara, Jun Kato, Yuya Koda, Kohei Shiroshita, Kentaro Yamaguchi, Mikio Okayama, Ryohei Abe, Taku Kikuchi, Takayuki Shimizu, Takehiko Mori, Keisuke Kataoka, Shinichiro Okamoto
Publikováno v:
Internal Medicine; 2024, Vol. 63 Issue 11, p1549-1562, 14p
Autor:
Yuho Najima, Takayoshi Tachibana, Yusuke Takeda, Yuya Koda, Yasuhisa Aoyama, Takashi Toya, Aiko Igarashi, Masatsugu Tanaka, Emiko Sakaida, Ryohei Abe, Makoto Onizuka, Takeshi Kobayashi, Noriko Doki, Kazuteru Ohashi, Heiwa Kanamori, Takuma Ishizaki, Akira Yokota, Satoshi Morita, Shinichiro Okamoto, Yoshinobu Kanda
Publikováno v:
Annals of Hematology. 101:2719-2729
This 3+3 dose-escalation phase I multicenter study investigated the optimal dose of azacitidine (AZA) for post-hematopoietic stem cell transplantation (HSCT) maintenance, which remains unknown in Japan. Recipients of a first HSCT for high-risk myelod
Autor:
Masaki Murata, Ryohei Abe
Publikováno v:
2022 Joint 12th International Conference on Soft Computing and Intelligent Systems and 23rd International Symposium on Advanced Intelligent Systems (SCIS&ISIS).
Autor:
Shinya Fujita, Masatoshi Sakurai, Hidenori Kasahara, Jun Kato, Yuya Koda, Kentaro Yamaguchi, Kohei Shiroshita, Mikio Okayama, Ryohei Abe, Taku Kikuchi, Takayuki Shimizu, Takehiko Mori, Keisuke Kataoka, Shinichiro Okamoto
Second- and third-generation (2/3G) tyrosine kinase inhibitors (TKIs) possess excellent treatment effects on chronic myeloid leukemia (CML), and at least one 2/3G TKI is mostly incorporated into the first treatment of CML in all phases. However, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2d7f3963727f09ecbe84d03b40fc7f25
https://doi.org/10.21203/rs.3.rs-2050971/v1
https://doi.org/10.21203/rs.3.rs-2050971/v1
Autor:
Kota Mizuno, Masatoshi Sakurai, Jun Kato, Kentaro Yamaguchi, Ryohei Abe, Yuya Koda, Keisuke Kataoka, Takehiko Mori
Publikováno v:
Transplant Infectious Disease. 24
Letermovir has been approved as a novel cytomegalovirus (CMV) prophylactic agent after allogeneic hematopoietic stem cell transplantation (HSCT). However, there are still insufficient data to properly evaluate the real-world role of letermovir, and t
Autor:
Rie Yamazaki, Yohei Tomita, Taku Kikuchi, Miki Koh, Masuho Saburi, Sumiko Kohashi, Yoko Ozawa, Jun Kato, Masatoshi Sakurai, Yuya Koda, Ryohei Abe, Takehiko Mori
Publikováno v:
Bone Marrow Transplantation. 56:1266-1271
Although cytomegalovirus (CMV) remains a leading cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (HSCT), the incidence of CMV retinitis is considered to be lower than the incidence of CMV infection in other o
Autor:
Kenji Yokoyama, Seishi Ogawa, Ryohei Abe, Yasuhito Nannya, Masatoshi Sakurai, Takehiko Mori, Rie Yamazaki, Kentaro Yamaguchi, Yuya Koda
Publikováno v:
Annals of Hematology. 101:237-239